Format

Send to

Choose Destination
South Asian J Cancer. 2019 Jan-Mar;8(1):1-17. doi: 10.4103/sajc.sajc_227_18.

Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line - Indian consensus statement update.

Author information

1
Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.

Abstract

The management of advanced nonsmall cell lung cancer (NSCLC) patients is becoming increasingly complex with the identification of driver mutations/rearrangements and development/availability of appropriate targeted therapies. In 2017, an expert group of medical oncologists with expertise in treating lung cancer used data from published literature and experience to arrive at practical consensus recommendations on treatment of advanced NSCLC for use by the community oncologists. This was published subsequently in the Indian Journal of Cancer with a plan to be updated annually. The present document is an update to the 2017 document.

KEYWORDS:

Consensus statement; driver mutations; nonsmall cell lung cancer; targeted therapies

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center